JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 11 2044-2048
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, K. A.
Right arrow Articles by Holman, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, K. A.
Right arrow Articles by Holman, B. L.

Quantitative Brain SPECT in Alzheimer's Disease and Normal Aging

Keith A. Johnson, Marie F. Kijewski, J. Alex Becker, Basem Garada, Andrew Satlin and B. Leonard Holman

Departments of Medicine (Neurology Division) and Radiology, Brigham and Women's Hospital
Harvard Medical School, Boston, Massachusetts
Departments of Neurology and Psychiatry and Magnetic Resonance Imaging Center, McLean Hospital, Belmont, Massachusetts
Department of Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts

Correspondence: For correspondence and reprints contact: Keith A. Johnson, MD, Dept. of Radiology, Brigham and Women's Hospital, Boston, MA 02115.

ABSTRACT

To improve the diagnostic utility of brain single-photon emission computed tomography (SPECT) in Alzheimer's disease (AD), we have developed and evaluated an objective method of differentiating patients and healthy elderly controls using a quantitative image analysis protocol. HMPAO-SPECT image datasets from 29 patients with probable AD and 78 age-matched controls were registered to a common anatomic frame of reference. Activity levels within 120 standardized cortical volumes were determined by an automated procedure. Subjects were classified into normal and AD groups by quadratic discriminant analysis using two features: global average activity level and average normalized activity levels within the two clusters of standardized volumes identified as most significantly different in AD by analysis of covariance. The classification used split-half replication to ensure valid results. Classification performance quantified by the area under a binormal ROC curve fitted to the data was 0.923 ± 0.036; at a threshold likelihood ratio of 1, the sample sensitivity was 91% and specificity was 86%. We conclude that quantitative SPECT accurately distinguishes AD patients from elderly controls.




This article has been cited by other articles:


Home page
AJGPHome page
H. H. Kyomen, J. Hennen, T. H. Whitfield, P. F. Renshaw, G. L. Gottlieb, and J. M. Gorman
Greater Depression Severity in Elderly Patients With Memory Complaints Is Associated With Decreased Left Temporal-Parietal Dominance Indicated by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Cerebral Blood Volume Measures
Am J Geriatr Psychiatry, July 1, 2007; 15(7): 604 - 610.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
N. J. Dougall, S. Bruggink, and K. P. Ebmeier
Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
Am J Geriatr Psychiatry, December 1, 2004; 12(6): 554 - 570.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Grossman, C. McMillan, P. Moore, L. Ding, G. Glosser, M. Work, and J. Gee
What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration
Brain, March 1, 2004; 127(3): 628 - 649.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. Neugroschl and K. L. Davis
Biological Markers in Alzheimer Disease
Am J Geriatr Psychiatry, December 1, 2002; 10(6): 660 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
X. M. Zheng
Detecting Regional Cerebral Blood Flow Changes in Alzheimer's Patients After Milameline Treatment: Activation or Baseline SPECT?
J. Nucl. Med. Technol., September 1, 2002; 30(3): 118 - 122.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K.A. Johnson, F. Lopera, K. Jones, A. Becker, R. Sperling, J. Hilson, J. Londono, I. Siegert, M. Arcos, S. Moreno, et al.
Presenilin-1-associated abnormalities in regional cerebral perfusion
Neurology, June 12, 2001; 56(11): 1545 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Bozzao, R. Floris, M. E. Baviera, A. Apruzzese, and G. Simonetti
Diffusion and Perfusion MR Imaging in Cases of Alzheimer's Disease: Correlations with Cortical Atrophy and Lesion Load
AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. S. Knopman, S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, G. W. Small, B. Miller, and J. C. Stevens
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 8, 2001; 56(9): 1143 - 1153.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. M. Hoffman, K. A. Welsh-Bohmer, M. Hanson, B. Crain, C. Hulette, N. Earl, and R. E. Coleman
FDG PET Imaging in Patients with Pathologically Verified Dementia
J. Nucl. Med., November 1, 2000; 41(11): 1920 - 1928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.